SCHEMBL29433715

SCHEMBL29433715

OC1OC=Cc2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.38
CYP2D6 P10635 2/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
KDM4E B2RXH2 2/20 0.31
BRD4 O60885 1/20 0.31
CCL2 P13500 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
CHRM2 P08172 1/20 0.31
CYP3A4 P08684 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD2 P14416 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
NFKB1 P19838 1/20 0.31
CHRM3 P20309 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4390027 1.00 HTR2A (0.38) HTR2ACYP2D6MAOAMAOBKDM4E
SCHEMBL4393423 0.82 MAOA (0.33) MAOAMAOB
SCHEMBL9817817 0.77 MAOA (0.38) HTR2ACYP2D6MAOAMAOBMEN1
SCHEMBL2006251 0.74 HTR2A (0.42) HTR2ACYP2D6KDM4EBRD4CCL2
SCHEMBL16398711 0.74 HTR2A (0.38) HTR2ACYP2D6KDM4EBRD4CCL2
SCHEMBL292481 0.74 BRD4 (0.38) HTR2ACYP2D6KDM4EBRD4CCL2
SCHEMBL292479 0.74 HTR2A (0.38) HTR2ACYP2D6KDM4EBRD4CCL2
SCHEMBL28793125 0.74 HTR2A (0.34) HTR2ACYP2D6KDM4EBRD4CCL2
SCHEMBL9934350 0.74 HTR2A (0.38) HTR2ACYP2D6KDM4ELMNATP53
SCHEMBL299075 0.72 EDNRA (0.37) HTR2ACYP2D6BRD4CCL2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118055766-A Magic and non-magic serotonin receptor agonist and its preparing process and usage 库莱恩有限责任公司 2024-05-17 CN disclosed
CN-117136050-A Compositions and methods for treating neuronal disorders using cannabinoids 因美制药公司 2023-11-28 CN disclosed
CN-115038786-A Optimized tetrahydrocannabinolic acid (THCA) synthase polypeptides 德美崔克斯公司 2022-09-09 CN disclosed
CN-114729337-A Optimized cannabinoid synthase polypeptides 德美崔克斯公司 2022-07-08 CN disclosed
EP-3958856-A1 COMPOSITIONS AND METHODS FOR USE OF CANNABINOIDS FOR NEUROPROTECTION Inmed Pharmaceuticals Inc. (CA) 2022-03-02 EP disclosed
CN-114007603-A Compositions and methods for neuroprotection using cannabinoids 因美制药公司 2022-02-01 CN disclosed